Recent Finacing
Recent Raise
ELIAS Animal Health develops ECI®, an adoptive cell therapy for canine osteosarcoma, pursuing USDA approval and commercial launch, with oncolytic immunotherapies and pilot studies with checkpoint inhibitors and surgery.
Focus Areas
Total Raised
Funding round
See the team members at ELIAS Animal Health.
